2018
DOI: 10.25270/jcp.2018.12.00052
|View full text |Cite
|
Sign up to set email alerts
|

Value-Based Clinical Pathways in the World of Reference-Priced Medicare Part B Drugs

Abstract: is an independent, not-for-profit research organisation whose mission is to improve policy and decision making for the public good. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors. R ® is a registered trademark.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 7 publications
(12 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?